These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 37114853

  • 1. Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice.
    Trinka E, Alsaadi T, Goji H, Maehara T, Takahashi S, Jacobs J, Renna R, Gil-López FJ, McMurray R, Sáinz-Fuertes R, Villanueva V.
    Epilepsia; 2023 Aug; 64(8):2094-2107. PubMed ID: 37114853
    [Abstract] [Full Text] [Related]

  • 2. Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.
    D'Souza W, Alsaadi T, Montoya J, Carreño M, Di Bonaventura C, Mohanraj R, Yamamoto T, McMurray R, Shastri O, Villanueva V, PERMIT study group.
    Seizure; 2022 Aug; 100():56-66. PubMed ID: 35777333
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study.
    Delanty N, Mohanraj R, Shankar R, Wehner T, Stephen LJ, D'Souza W, Cappucci S, McMurray R, Sainz-Fuertes R, Villanueva V.
    Epilepsy Res; 2024 May; 202():107339. PubMed ID: 38492461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.
    Villanueva V, D'Souza W, Goji H, Kim DW, Liguori C, McMurray R, Najm I, Santamarina E, Steinhoff BJ, Vlasov P, Wu T, Trinka E, PERMIT pooled analysis participants.
    J Neurol; 2022 Apr; 269(4):1957-1977. PubMed ID: 34427754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
    Alonso-Singer P, Aguilar-Amat Prior MJ, Oliva-Navarro J, Massot-Tarrús A, Giráldez BG, Bermejo P, DeToledo-Heras M, Aledo-Serrano Á, Martínez-Cayuelas E, Tirado-Requero P, Velázquez-Fragua R, López-Sobrino G, Ojeda J.
    Epilepsy Behav; 2022 Sep; 134():108836. PubMed ID: 35870432
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry.
    Toledano Delgado R, García-Morales I, Parejo-Carbonell B, Jiménez-Huete A, Herrera-Ramirez D, González-Hernández A, Ayuga Loro F, Santamarina E, Toledo M, Ojeda J, Poza JJ, Molins A, Giner P, Estévez María JC, Castro-Vilanova MD, Zurita J, Saiz-Diaz RA, Gómez-Ibañez A, Rodriguez-Uranga J, Gil-Nagel A, Campos D, Sánchez-Larsen Á, Aguilar-Amat Prior MJ, Mauri Llerda JA, Huertas González N, García-Barragán N.
    Epilepsia; 2020 Jun; 61(6):1109-1119. PubMed ID: 32511754
    [Abstract] [Full Text] [Related]

  • 11. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.
    Gil-López FJ, Montoya J, Falip M, Aparicio J, López-González FJ, Toledano R, Gil-Nagel A, Molins A, García I, Serrano P, Domenech G, Torres F, Donaire A, Carreño M.
    Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400
    [Abstract] [Full Text] [Related]

  • 12. Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures.
    Trinka E, Lattanzi S, Carpenter K, Corradetti T, Nucera B, Rinaldi F, Shankar R, Brigo F.
    CNS Drugs; 2021 Aug; 35(8):821-837. PubMed ID: 34232492
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy.
    Rohracher A, Brigo F, Höfler J, Kalss G, Neuray C, Dobesberger J, Kuchukhidze G, Leitinger M, Trinka E.
    Expert Opin Pharmacother; 2016 Jul; 17(10):1403-11. PubMed ID: 27267634
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 18. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.
    Fogarasi A, Flamini R, Milh M, Phillips S, Yoshitomi S, Patten A, Takase T, Laurenza A, Ngo LY.
    Epilepsia; 2020 Jan; 61(1):125-137. PubMed ID: 31912493
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of Phase II and Phase III double-blind and open-label extension studies in India.
    Mehndiratta MM, Gulhane M, Jabeen SA, Patten A, Dash A, Malhotra M.
    Epilepsia Open; 2021 Mar; 6(1):90-101. PubMed ID: 33681652
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.